M. Chaluvadi

BIOFLAVONOIDS CLASSIFICATION, PHARMACOLOGICAL, BIOCHEMICAL EFFECTS AND THERAPEUTIC POTENTIAL

D. Narayana, R. Sripal, M. Chaluvadi, 2001 .

Hepatic Flavin-Containing Monooxygenase Gene Regulation in Different Mouse Inflammation Models

T. A. Richardson, J. Cashman, M. Chaluvadi, 2009, Drug Metabolism and Disposition.

Regulation of Drug-Metabolizing Enzymes and Transporters in Infection, Inflammation, and Cancer

Micheline Piquette-Miller, T. A. Richardson, Graham R Robertson, 2008, Drug Metabolism and Disposition.

Symposium Report Regulation of Drug-Metabolizing Enzymes and Transporters in Infection, Inflammation, and Cancer

T. A. Richardson, S. Clarke, C. Liddle, 2008 .

Influence of Rifampicin Pretreatment on the Pharmacokinetics of Tinidazole in Healthy Male Volunteers

D. Krishna, M. Chaluvadi, M. R. Chaluvadi, 2001 .

Validated HPLC method for determination of PAT-5A, an insulin sensitizing agent, in rat plasma.

S. Shreeram, S. Subramaniam, M. Chaluvadi, 2000, Journal of pharmaceutical and biomedical analysis.

Regulation of Hepatic Cytochrome P450 Expression in Mice with Intestinal or Systemic Infections of Citrobacter rodentium

T. A. Richardson, H. Strobel, M. Sherman, 2009, Drug Metabolism and Disposition.

TLR4-dependent and -independent regulation of hepatic cytochrome P450 in mice with chemically induced inflammatory bowel disease.

M. Chaluvadi, E. Morgan, Beatrice A. Nyagode, 2009, Biochemical pharmacology.

Intravenous pharmacokinetics, oral bioavailability and dose proportionality of ragaglitazar, a novel PPAR‐dual activator in rats

M. Chaluvadi, N. Srinivas, R. Mullangi, 2004, Biopharmaceutics & drug disposition.